Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
Dec. 21, 2021— by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...
Dec. 20, 2021—Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time.
Dec. 17, 2021—Vanderbilt cancer patient Brody Cramer knows all too well how crucial blood donations are. Since he was diagnosed with leukemia earlier this year he has needed 23 units of red blood cells and 16 units of platelets.
Silver appointed to national committee assessing human requirements for energy intake and expenditure
Dec. 17, 2021—Vanderbilt's Heidi Silver, PhD, RDN, MS, has been appointed to an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine to assess the human requirements for energy intake and expenditure.
Dec. 17, 2021— by Jessica Pasley While teen driver fatalities have declined over the years, automobile crashes remain the leading cause of death among teens. Every day in the United States, nine people die from a distracted-driving motor vehicle crash, with six of these deaths being drivers between 16-19 years old. These statistics are part of the...
Dec. 16, 2021—The fight against COVID-19 carried on, but while the pandemic dominated the news in 2021, there were many other achievements that made headlines this year at Vanderbilt University Medical Center.
Dec. 16, 2021—Vanderbilt University Medical Center placed highly in several national rankings and was honored with numerous awards during the past year.
Dec. 16, 2021—New leadership appointments during the past year helped strengthen Vanderbilt University Medical Center's core missions.
Dec. 16, 2021—Vanderbilt research is blazing a trail for the application of game theory to genomic and health data reidentification risk.
Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.